Advertisement

Topics

ProSolv CardioVascular Company Profile

01:52 EST 19th November 2017 | BioPortfolio

Founded in 1989 as Problem Solving Concepts, Inc. (ProSolv) and acquired by FUJIFILM Medical Systems in January 2007, the company is a leading provider of enterprise-level information management solutions for the clinical analysis and management of digital medical images for cardiology. ProSolv CardioVascular's software solutions consist of advanced reporting and image management software, comprehensive support services and integration with third-party clinical applications. The Synapse(TM) ProSolv(R) cardiovascular Enterprise Image and Information Management solution improves physician productivity, enhances customer revenue opportunities, automates complex medical imaging workflow, and maximizes customers' return on investment in capital equipment and clinical information systems. The company is headquartered in Indianapolis, Indiana. For more information visit the ProSolv CardioVascular website at www.prosolv.com.


News Articles [433 Associated News Articles listed on BioPortfolio]

Takeda, Cardurion Pharmaceuticals partner on cardiovascular development

Takeda Pharmaceutical and Cardurion Pharmaceuticals announced the creation of a new cardiovascular development partnership. Cardurion, a recently launched Boston-area based biotechnology company, is f...

Pericardial fat—not liver fat—associated with higher cardiovascular disease risk

Fat surrounding the

AUM Cardiovascular receives FDA clearance for diagnostic ECG system

AUM Cardiovascular has received clearance from the Food and Drug Administration (FDA) for its non-invasive acoustic and ECG device. The CADence device uses recorded sounds from a patient's heart and p...

One year results from the REDUCE trial reported at TCT 2017

(Cardiovascular Research Foundation) Results from the prospective, multicenter, randomized investigator-initiated REDUCE trial were reported today at the 29th annual Transcatheter Cardiovascular Thera...

Announcing the TCT 2017 press conference schedule

(Cardiovascular Research Foundation) The Cardiovascular Research Foundation (CRF) has announced the press conference schedule for late-breaking trials and first report investigations that will be pres...

Canagliflozin Reduces Cardiovascular Events in Diabetic Patients

Canagliflozin resulted in a lower risk of cardiovascular disease in type 2 diabetics who were at high cardiovascular risk. However, there was a higher risk of amputation, which is a new finding.

A Rivaroxaban/Daily Low-dose Aspirin Combination and Cardiovascular Events

The addition of rivaroxaban to daily low-dose aspirin resulted in fewer cardiovascular outcomes and increased major bleeding compared to aspirin alone in patients with stable cardiovascular disease.

Announcing the TCT 2017 late-breaking trials and first report investigations

(Cardiovascular Research Foundation) The Cardiovascular Research Foundation (CRF) has announced the 12 late-breaking trials and 16 first report investigations that will be presented at the Transcathet...

PubMed Articles [1713 Associated PubMed Articles listed on BioPortfolio]

Navigating the Future of Cardiovascular Drug Development-Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference.

The need for novel approaches to cardiovascular drug development served as the impetus to convene an open meeting of experts from the pharmaceutical industry and academia to assess the challenges and ...

Cardiovascular Disease in Korean Americans: A Systematic Review.

Despite Korean Americans being one of the fastest growing immigrant groups in the United States, little is known about their cardiovascular health or cardiovascular disease risk factors.

Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI).

To develop a document by Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI) to review and summarize the most recent evidences about the no...

Cardiovascular Effects of Antidiabetic Therapies.

Type 2- diabetes mellitus (T2DM) represents a major risk factor for cardiovascular complications and mortality. Strict glucose control in the early course of the disease prevents cardiovascular compli...

A Systematic Review of Interventions to Improve Health Factors or Behaviors of the Cardiovascular Health of Prisoners During Incarceration.

Prisoners are disproportionately affected by cardiovascular disease and its risk factors. However, primary prevention of cardiovascular disease in correctional settings has been widely neglected, and ...

Clinical Trials [2432 Associated Clinical Trials listed on BioPortfolio]

Factors Influencing Cardiovascular Prognosis

The purpose of this study is to identify risks for cardiovascular events in a follow up period of 10 years.

Work Organization and Cardiovascular Disease

To determine the combined effects of job strain and social isolation on cardiovascular morbidity and mortality.

Role of Vitamin D in Secondary Prevention of Cardiovascular Events

The purpose of this study is to determine if Vitamin D supplementation helps prevent recurrent cardiovascular events, such as heart attack or stroke, in patients who have already experienc...

Partnership Programs for Reducing Cardiovascular Disparities in Native Hawaiians

The purpose of this study is to improve cardiovascular disease (CVD) outcomes in racial and ethnic minorities in Hawaii.

Genetics and Cardiovascular Reactivity in Young Twins

To evaluate the effects of genetic variants in all of the nine adrenergic receptor subtype genes, alone or in combination, on cardiovascular reactivity and other quantitative cardiovascula...

Companies [589 Associated Companies listed on BioPortfolio]

ProSolv CardioVascular

Founded in 1989 as Problem Solving Concepts, Inc. (ProSolv) and acquired by FUJIFILM Medical Systems in January 2007, the company is a leading provider of enterprise-level information management solut...

Cardiovascular Consultants, Ltd.

Cardiovascular Consultants, Ltd., founded in 1986 by Dr. Andrei Damian, is dedicated to providing patients in Phoenix and surrounding areas with the most advanced and appropriate ...

Cardiovascular Consultants Ltd.

Cardiovascular Consultants Ltd., founded in 1986 by Dr. Andrei Damian, is dedicated to providing patients in Phoenix and surrounding areas with the most advanced and appropriate c...

Embrella Cardiovascular, Inc.

Embrella Cardiovascular™, Inc., is dedicated to creating a new standard-of-care for cerebral embolic protection during cardiovascular procedures. Embrella's Embolic Deflector...

Cardiovascular Consultants

Cardiovascular Consultants is a medical practice that specializes exclusively in the diagnosis, treatment, prevention and management of cardiovascular diseases and conditions. What makes us different ...

More Information about "ProSolv CardioVascular" on BioPortfolio

We have published hundreds of ProSolv CardioVascular news stories on BioPortfolio along with dozens of ProSolv CardioVascular Clinical Trials and PubMed Articles about ProSolv CardioVascular for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ProSolv CardioVascular Companies in our database. You can also find out about relevant ProSolv CardioVascular Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record